{"transactions":[{"id":3010602,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":146063,"kind":"person","name":"Graham Camilla","position":1,"cik":"0001827543","reported_name":"Graham Camilla","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Affairs Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-07T23:47:55.000Z","date":"2020-10-04","kind":"grant","acquired":true,"shares":400000,"price":3.34,"value":1336000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on October 4, 2020 pursuant to the Company's 2020 Stock Incentive Plan. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on October 4, 2021, subject to the satisfaction of certain performance targets."}],"balance_after":400000,"derivative":{"exercise_price":3.34,"expiration_date":"2030-10-04","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000921895-20-002557","document":"form412566002_10072020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000092189520002557/form412566002_10072020.xml","form_type":"4"}}]}